Biogen Halves Aduhelm Price, Readies $500m In Cost Cuts
Potential Job Losses Loom As Holidays Approach
The Alzheimer’s drug’s price was cut to $28,200 per year just one month before CMS is expected to issue a draft national coverage determination for amyloid-clearing antibodies, raising questions about the timing.
